Unlock instant, AI-driven research and patent intelligence for your innovation.

Amyloid protein oligomer conformation type epitope polypeptide and application thereof

A technology of amyloid protein and antigenic epitope, applied in the direction of peptides, metabolic diseases, nervous system diseases, etc., can solve the problems of patient death, achieve good immunogenicity, and eliminate side effects

Active Publication Date: 2012-11-14
TSINGHUA UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, unfortunately in the second phase of clinical trials, although most patients still showed good results, 6% of patients showed symptoms and pathological changes of meningitis, and some patients even died

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amyloid protein oligomer conformation type epitope polypeptide and application thereof
  • Amyloid protein oligomer conformation type epitope polypeptide and application thereof
  • Amyloid protein oligomer conformation type epitope polypeptide and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] A polypeptide (PEOZ for short), whose amino acid sequence is: Cys-Ser-His-Ala-Leu-His-Asn-Asn-Cys, or one or more amino acids are substituted, deleted, or added to the above-mentioned amino acid sequence, And it has the function of inhibiting the aggregation of amyloid protein. The invention can effectively stimulate the body to produce a specific antibody for recognizing the amyloid oligomer, and the antibody can inhibit the aggregation and cytotoxicity of the amyloid protein.

[0024]The N-terminus of the polypeptide was modified with PEG2000 (sequence: PEG-Cys-Ser-His-Ala-Leu-His-Asn-Asn-Cys), and alanine was deleted (sequence: Cys-Ser-His-Leu -His-Asn-Asn-Cys), replacement of serine with alanine (sequence: Cys-Ala-His-Ala-Leu-His-Asn-Asn-Cys) or insertion of alanine (sequence: Cys-Ser -His-Ala-Leu-His-Asn-Asn-Cys), the test shows that the PEOZ polypeptide can still retain the ability to bind to A11 after certain modifications, a certain amino acid is replaced, dele...

Embodiment 2

[0034] Example 2: Binding of PEOZ to polyclonal antibody A11

[0035] Coat 100 μl of PEOZ (1 mg / well) on a 96-well ELISA microplate (with no PEOZ-coated wells as a control), place at 37°C for 2 h, block with 3% BSA at 37°C for 2 h, 200 μL / well. Wash the plate 3 times with PBS. Add 100 μl A11 (1:500) to each well, incubate at room temperature for 1 h, and wash 3 times with PBS containing 0.1% Tween-20. After incubation at room temperature for 1 h, the cells were washed 3 times with PBS containing 0.1% Tween-20. Add 100 μl diluted goat anti-rabbit HRP enzyme-labeled secondary antibody (1:5000) to each well, incubate at room temperature for 1 h, and wash 3 times with PBS containing 0.1% Tween-20. Add 100 μL of substrate solution TMB to each well, place at 37°C for 20 min, then add 50 μl of 1 mmol / L sulfuric acid to each well to stop the reaction, and measure the OD value (wavelength 450 nm) on an enzyme-linked immunosorbent detector. figure 1 The indicated PEOZ can be specifi...

Embodiment 3

[0036] Example 3: PEOZ with substituted, deleted or inserted amino acids still binds to A11

[0037] The N-terminus of PEOZ was modified with PEG2000 (referred to as PEG-PEOZ) (sequence: PEG-Cys-Ser-His-Ala-Leu-His-Asn-Asn-Cys), and alanine was deleted (referred to as: PEOZ- ?A) (sequence: Cys-Ser-His-Leu-His-Asn-Asn-Cys), serine replaced by alanine (referred to as PEOZ-S / A) (sequence: Cys-Ala-His-Ala -Leu-His-Asn-Asn-Cys) or inserted alanine (abbreviation: PEOZ-G) (sequence: Cys-Ser-His-Ala-Leu-His-Asn-Asn-Cys). In order to detect the binding of the modified polypeptides to A11, these polypeptides were combined with the unmodified PEOZ with a histidine tag to compete with A11, and then ELISA was used to detect the binding of the latter to A11. Add 100 ml of the mixture of 1 mg unmodified tagged PEOZ and 10 mg modified PEOZ into the wells coated with A11, then use ELISA to detect the combination of tagged PEOZ and A11, and measure the OD value, see results figure 2 . It s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of peptide-containing medical preparations, in particular relating to an amyloid protein oligomer conformation type epitope polypeptide and an application thereof. The epitope polypeptide is used for preparing an antibody which can identify a plurality of amyloid protein oligomers for the diagnosis, treatment and experimental research of amyloid protein diseases. The invention provides the amyloid protein oligomer conformation type epitope polypeptide (PEOZ) the amino acid sequence of which is Cys-Ser-His-Ala-Leu-His-Asn-Asn-Cys or is obtained by replacing, deleting or adding one or more of amino acid residues to the amino acid sequence. The epitope polypeptide can effectively stimulate an organism to generate the specific antibody which can identify amyloid protein oligomers and the antibody can inhibit the aggregation of the amyloid protein and the cytotoxicity.

Description

technical field [0001] The invention belongs to the field of peptide-containing pharmaceutical preparations, and specifically relates to an amyloid oligomer conformational epitope polypeptide and its application; the invention is applied to the preparation of amyloid with antibodies that recognize various amyloid oligomers Disease diagnosis, treatment and experimental research. Background technique [0002] Over the years, various diseases caused by the aggregation of amyloid or polypeptide itself have caused more and more harm to human health. Some proteins themselves are non-toxic or have very little toxicity, but they themselves can aggregate into toxic oligomers (oligomer) or fibrils (fibril) and cause a series of diseases, such as Beta-amyloid (A-Beta) Alzheimer's disease (commonly known as senile dementia) (Alzheimer'disease, AD), caused by alpha-synuclein (Parkinson' disease, PD), caused by prion protein (Prion protein (PrP)) At least ten kinds of encephalopathy in ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K7/06A61K38/08A61P25/16A61P3/10A61P25/00
Inventor 刘瑞田赵敏
Owner TSINGHUA UNIV